Onalabs — Series A (estimated) · ~approximately €9.3M

Deeptech Onalabs raised more than €9.3M to scale its non-invasive sweat-based biosensors, with SETT contributing €4.6M through the Next Tech facility. Funds go to industrialising OnaSport, clinical validation of OnaVital and developing diabetes solutions; the company holds six patents and works with FC Barcelona's innovation hub and Garmin.

Lead not disclosed RoundSeries A (estimated) Announced27 Jul 2026 CityCerdanyola del Vallès · reported Barcelona SectorHealthtech & Bio · Healthtech Source E S

Something wrong? Suggest a correction →